Tag: NASDAQ: DVAX

Business

Dynavax Technologies Corporation (NASDAQ: DVAX) and Biological E enter into a Commercial Supply Agreement of Dynavax’s CpG 1018 Advanced Adjuvant

With the uncertainty caused by the COVID-19 pandemic, many institutions have had to refocus to ensure they are only investing in critical business areas. Dynavax Technologies Corporation (Nasdaq: DVAX) is one of those that has acted quickly to safeguard the health and safety of its employees and customers. And in […]